These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28234741)

  • 1. Concomitant Use of Panobinostat and Reirradiation in Progressive DIPG: Report of 2 Cases.
    Wang ZJ; Ge Y; Altinok D; Poulik J; Sood S; Taub JW; Edwards H; Kieran MW; Steven M
    J Pediatr Hematol Oncol; 2017 Aug; 39(6):e332-e335. PubMed ID: 28234741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-Clinical Study of Panobinostat in Xenograft and Genetically Engineered Murine Diffuse Intrinsic Pontine Glioma Models.
    Hennika T; Hu G; Olaciregui NG; Barton KL; Ehteda A; Chitranjan A; Chang C; Gifford AJ; Tsoli M; Ziegler DS; Carcaboso AM; Becher OJ
    PLoS One; 2017; 12(1):e0169485. PubMed ID: 28052119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functionally defined therapeutic targets in diffuse intrinsic pontine glioma.
    Grasso CS; Tang Y; Truffaux N; Berlow NE; Liu L; Debily MA; Quist MJ; Davis LE; Huang EC; Woo PJ; Ponnuswami A; Chen S; Johung TB; Sun W; Kogiso M; Du Y; Qi L; Huang Y; Hütt-Cabezas M; Warren KE; Le Dret L; Meltzer PS; Mao H; Quezado M; van Vuurden DG; Abraham J; Fouladi M; Svalina MN; Wang N; Hawkins C; Nazarian J; Alonso MM; Raabe EH; Hulleman E; Spellman PT; Li XN; Keller C; Pal R; Grill J; Monje M
    Nat Med; 2015 Jun; 21(6):555-9. PubMed ID: 25939062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047).
    Monje M; Cooney T; Glod J; Huang J; Peer CJ; Faury D; Baxter P; Kramer K; Lenzen A; Robison NJ; Kilburn L; Vinitsky A; Figg WD; Jabado N; Fouladi M; Fangusaro J; Onar-Thomas A; Dunkel IJ; Warren KE
    Neuro Oncol; 2023 Dec; 25(12):2262-2272. PubMed ID: 37526549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase Ia/II, two-arm, open-label, dose-escalation study of oral panobinostat administered via two dosing schedules in patients with advanced hematologic malignancies.
    DeAngelo DJ; Spencer A; Bhalla KN; Prince HM; Fischer T; Kindler T; Giles FJ; Scott JW; Parker K; Liu A; Woo M; Atadja P; Mishra KK; Ottmann OG
    Leukemia; 2013 Aug; 27(8):1628-36. PubMed ID: 23385375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation and subsequent reirradiation outcomes in the treatment of diffuse intrinsic pontine glioma and a systematic review of the reirradiation literature.
    Freese C; Takiar V; Fouladi M; DeWire M; Breneman J; Pater L
    Pract Radiat Oncol; 2017; 7(2):86-92. PubMed ID: 28274399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Panobinostat active against diffuse intrinsic pontine glioma.
    Bagcchi S
    Lancet Oncol; 2015 Jun; 16(6):e267. PubMed ID: 25971867
    [No Abstract]   [Full Text] [Related]  

  • 8. Reirradiation in patients with diffuse intrinsic pontine gliomas: The Canadian experience.
    Lassaletta A; Strother D; Laperriere N; Hukin J; Vanan MI; Goddard K; Lafay-Cousin L; Johnston DL; Zelcer S; Zapotocky M; Rajagopal R; Ramaswamy V; Hawkins C; Tabori U; Huang A; Bartels U; Bouffet E
    Pediatr Blood Cancer; 2018 Jun; 65(6):e26988. PubMed ID: 29369515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reirradiation and PD-1 inhibition with nivolumab for the treatment of recurrent diffuse intrinsic pontine glioma: a single-institution experience.
    Kline C; Liu SJ; Duriseti S; Banerjee A; Nicolaides T; Raber S; Gupta N; Haas-Kogan D; Braunstein S; Mueller S
    J Neurooncol; 2018 Dec; 140(3):629-638. PubMed ID: 30206764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group.
    Janssens GO; Gandola L; Bolle S; Mandeville H; Ramos-Albiac M; van Beek K; Benghiat H; Hoeben B; Morales La Madrid A; Kortmann RD; Hargrave D; Menten J; Pecori E; Biassoni V; von Bueren AO; van Vuurden DG; Massimino M; Sturm D; Peters M; Kramm CM
    Eur J Cancer; 2017 Mar; 73():38-47. PubMed ID: 28161497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase I trial of panobinostat and epirubicin in solid tumors with a dose expansion in patients with sarcoma.
    Thomas S; Aggarwal R; Jahan T; Ryan C; Troung T; Cripps AM; Raha P; Thurn KT; Chen S; Grabowsky JA; Park J; Hwang J; Daud A; Munster PN
    Ann Oncol; 2016 May; 27(5):947-52. PubMed ID: 26903311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I study of oral panobinostat alone and in combination with docetaxel in patients with castration-resistant prostate cancer.
    Rathkopf D; Wong BY; Ross RW; Anand A; Tanaka E; Woo MM; Hu J; Dzik-Jurasz A; Yang W; Scher HI
    Cancer Chemother Pharmacol; 2010 May; 66(1):181-9. PubMed ID: 20217089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second re-irradiation for DIPG progression, re-considering "old strategies" with new approaches.
    Morales La Madrid A; Santa-María V; Cruz Martinez O; Mora J; Puerta Roldan P; Guillen Quesada A; Suñol Capella M; de Torres Gomez-Pallete C; Lassaletta A; Laperriere N; Villà S; Bouffet E
    Childs Nerv Syst; 2017 May; 33(5):849-852. PubMed ID: 28251325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase 1/2 study of oral panobinostat combined with melphalan for patients with relapsed or refractory multiple myeloma.
    Berenson JR; Hilger JD; Yellin O; Boccia RV; Matous J; Dressler K; Ghazal HH; Jamshed S; Kingsley EC; Harb WA; Noga SJ; Nassir Y; Swift RA; Vescio R
    Ann Hematol; 2014 Jan; 93(1):89-98. PubMed ID: 24135804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The HDACi Panobinostat Shows Growth Inhibition Both In Vitro and in a Bioluminescent Orthotopic Surgical Xenograft Model of Ovarian Cancer.
    Helland Ø; Popa M; Bischof K; Gjertsen BT; McCormack E; Bjørge L
    PLoS One; 2016; 11(6):e0158208. PubMed ID: 27352023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functionalized Macrophage Exosomes with Panobinostat and PPM1D-siRNA for Diffuse Intrinsic Pontine Gliomas Therapy.
    Shan S; Chen J; Sun Y; Wang Y; Xia B; Tan H; Pan C; Gu G; Zhong J; Qing G; Zhang Y; Wang J; Wang Y; Wang Y; Zuo P; Xu C; Li F; Guo W; Xu L; Chen M; Fan Y; Zhang L; Liang XJ
    Adv Sci (Weinh); 2022 Jul; 9(21):e2200353. PubMed ID: 35585670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Panobinostat plus bortezomib and dexamethasone: impact of dose intensity and administration frequency on safety in the PANORAMA 1 trial.
    San-Miguel JF; Hungria VTM; Yoon SS; Beksac M; Dimopoulos MA; Elghandour A; Jedrzejczak WW; Guenther A; Na Nakorn T; Siritanaratkul N; Schlossman RL; Hou J; Moreau P; Lonial S; Lee JH; Einsele H; Salwender H; Sopala M; Redhu S; Paul S; Corrado C; Richardson PG
    Br J Haematol; 2017 Oct; 179(1):66-74. PubMed ID: 28653400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single institution experience in re-irradiation of biopsy-proven diffuse intrinsic pontine gliomas.
    Zamora PL; Miller SR; Kovoor JJ
    Childs Nerv Syst; 2021 Aug; 37(8):2539-2543. PubMed ID: 33973056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I trial of panobinostat and fractionated stereotactic re-irradiation therapy for recurrent high grade gliomas.
    Shi W; Palmer JD; Werner-Wasik M; Andrews DW; Evans JJ; Glass J; Kim L; Bar-Ad V; Judy K; Farrell C; Simone N; Liu H; Dicker AP; Lawrence YR
    J Neurooncol; 2016 May; 127(3):535-9. PubMed ID: 26821711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Convection enhanced delivery of panobinostat (LBH589)-loaded pluronic nano-micelles prolongs survival in the F98 rat glioma model.
    Singleton WG; Collins AM; Bienemann AS; Killick-Cole CL; Haynes HR; Asby DJ; Butts CP; Wyatt MJ; Barua NU; Gill SS
    Int J Nanomedicine; 2017; 12():1385-1399. PubMed ID: 28260886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.